Literature DB >> 33424784

Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13.

Longxian Lv1, Gaolei Li2, Jinhui Chen3, Xinle Liang2, Yudong Li2.   

Abstract

BACKGROUND: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, rapidly grew into a global pandemic. How SARS-CoV-2 evolved remains unclear.
METHODS: We performed a comprehensive analysis using the available genomes of SARS-CoV-2 and its closely related coronaviruses.
RESULTS: The ratio of nucleotide substitutions to amino acid substitutions of the spike gene (9.07) between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 was markedly higher than that between other coronaviruses (range, 1.29-4.81); the ratio of non-synonymous to synonymous substitution rates (dN/dS) between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 was the lowest among all the performed comparisons, suggesting evolution under stringent selective pressure. Notably, the relative proportion of the T:C transition was markedly higher between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 than between other compared coronaviruses. Codon usage is similar across these coronaviruses and is unlikely to explain the increased number of synonymous mutations. Moreover, some sites of the spike protein might be subjected to positive selection.
CONCLUSIONS: Our results showed an increased proportion of synonymous substitutions and the T:C transition between SARS-CoV-2 and RaTG13. Further investigation of the mutation pattern mechanism would contribute to understanding viral pathogenicity and its adaptation to hosts.
Copyright © 2020 Lv, Li, Chen, Liang and Li.

Entities:  

Keywords:  Bat-CoV; SARS-CoV-2; codon usage; natural selection; synonymous mutation

Year:  2020        PMID: 33424784      PMCID: PMC7793997          DOI: 10.3389/fmicb.2020.584717

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  18 in total

1.  Nearly Neutral Evolution across the Drosophila melanogaster Genome.

Authors:  David Castellano; Jennifer James; Adam Eyre-Walker
Journal:  Mol Biol Evol       Date:  2018-11-01       Impact factor: 16.240

2.  Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses.

Authors:  Diego Forni; Rachele Cagliani; Alessandra Mozzi; Uberto Pozzoli; Nasser Al-Daghri; Mario Clerici; Manuela Sironi
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

3.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2014-01-21       Impact factor: 6.937

4.  Origin and Evolution of the 2019 Novel Coronavirus.

Authors:  Liangsheng Zhang; Fu-Ming Shen; Fei Chen; Zhenguo Lin
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.

Authors:  Xiao-Wei Xu; Xiao-Xin Wu; Xian-Gao Jiang; Kai-Jin Xu; Ling-Jun Ying; Chun-Lian Ma; Shi-Bo Li; Hua-Ying Wang; Sheng Zhang; Hai-Nv Gao; Ji-Fang Sheng; Hong-Liu Cai; Yun-Qing Qiu; Lan-Juan Li
Journal:  BMJ       Date:  2020-02-19

8.  Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Authors:  Xuan Jiang; Simon Rayner; Min-Hua Luo
Journal:  J Med Virol       Date:  2020-02-24       Impact factor: 2.327

9.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

10.  Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.

Authors:  Chengxin Zhang; Wei Zheng; Xiaoqiang Huang; Eric W Bell; Xiaogen Zhou; Yang Zhang
Journal:  J Proteome Res       Date:  2020-03-24       Impact factor: 4.466

View more
  11 in total

1.  Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).

Authors:  Neetu Tyagi; Rahila Sardar; Dinesh Gupta
Journal:  PeerJ       Date:  2022-06-23       Impact factor: 3.061

2.  Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.

Authors:  Aleksandra Gruca; Joanna Ziemska-Legiecka; Patryk Jarnot; Elzbieta Sarnowska; Tomasz J Sarnowski; Marcin Grynberg
Journal:  BMC Bioinformatics       Date:  2021-04-08       Impact factor: 3.169

Review 3.  SARS-CoV-2: The Monster Causes COVID-19.

Authors:  Chang Song; Zesong Li; Chen Li; Meiying Huang; Jianhong Liu; Qiuping Fang; Zitong Cao; Lin Zhang; Pengbo Gao; Wendi Nie; Xueyao Luo; Jianhao Kang; Shimin Xie; Jianxin Lyu; Xiao Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-08       Impact factor: 5.293

Review 4.  COVID-19 is a natural infectious disease.

Authors:  Zhenjun Li; Jiafu Jiang; Yigang Tong; Xiangdong Ruan; Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2021-12-11

5.  COVID-19 detection using X-ray images and statistical measurements.

Authors:  Emre Avuçlu
Journal:  Measurement (Lond)       Date:  2022-08-04       Impact factor: 5.131

6.  Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.

Authors:  Otun Saha; Israt Islam; Rokaiya Nurani Shatadru; Nadira Naznin Rakhi; Md Shahadat Hossain; Md Mizanur Rahaman
Journal:  Virus Genes       Date:  2021-07-12       Impact factor: 2.332

7.  A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.

Authors:  Lin Kang; Guijuan He; Amanda K Sharp; Xiaofeng Wang; Anne M Brown; Pawel Michalak; James Weger-Lucarelli
Journal:  Cell       Date:  2021-07-07       Impact factor: 66.850

8.  SARS-CoV-2 spillover transmission due to recombination event.

Authors:  Nariman Shahhosseini; Gary Wong; Gary P Kobinger; Sadegh Chinikar
Journal:  Gene Rep       Date:  2021-02-16

9.  Assessment of humoral responses in COVID-19 using various quantitative antibody tests.

Authors:  Masatoshi Wakui; Yoshifumi Uwamino; Toshinobu Kurafuji; Masayo Noguchi; Akemi Ohno; Hiromitsu Yokota; Haruhito Kikuchi; Naoki Hasegawa; Hideyuki Saya; Mitsuru Murata
Journal:  Ann Clin Biochem       Date:  2021-04-08       Impact factor: 2.057

10.  Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.

Authors:  Jacob Kames; David D Holcomb; Ofer Kimchi; Michael DiCuccio; Nobuko Hamasaki-Katagiri; Tony Wang; Anton A Komar; Aikaterini Alexaki; Chava Kimchi-Sarfaty
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.